Infectious Illness Symptoms Are Associated with Elevated Anxiety in a Sample of Sexual and Gender Minority Young Adults During the COVID-19 Pandemic.
Anxiety
COVID-19
Infectious illness symptoms
LGBTQ+
Mental health
Youth
Journal
International journal of behavioral medicine
ISSN: 1532-7558
Titre abrégé: Int J Behav Med
Pays: England
ID NLM: 9421097
Informations de publication
Date de publication:
19 Jan 2024
19 Jan 2024
Historique:
accepted:
12
12
2023
medline:
19
1
2024
pubmed:
19
1
2024
entrez:
19
1
2024
Statut:
aheadofprint
Résumé
To evaluate whether infectious illness symptoms (IIS) are associated with generalized anxiety symptoms during the COVID-19 pandemic in sexual/gender (SGM) minority young adults assigned male at birth (AMAB). Four hundred eighteen participants (median age = 25; range, 20-40) were recruited through RADAR, an ongoing Chicago-based cohort study of SGM-AMAB between September 2020 and February 2021. Participants completed online surveys. A subset (n = 145) provided dried blood spot samples to assess SARS-CoV-2 serostatus. One hundred twenty participants (28.7%) had GAD-7 scores of 10 or greater, which indicates generalized anxiety symptoms that may be clinically significant. In a binomial logistic regression model adjusting age, gender identity, race/ethnicity, substance use, and HIV status, the authors found that having a higher IIS count since March 1, 2020, was associated with greater odds of having a GAD-7 score of 10 or greater (OR = 1.14; 95% CI, 1.04, 1.25; P = 0.007). This effect was more pronounced in a binomial logistic regression model adjusting for the same covariates but using current IIS count as the independent variable (OR = 1.39; 95% CI, 1.13, 1.74; P = 0.002). Among SGM-AMAB young adults, those who experienced ISS reported higher scores on the GAD-7, a widely used and validated screening measure for generalized anxiety symptoms. These findings highlight the importance of screening for anxiety disorders when patients present with IIS in clinical settings and psychobehavioral health follow-ups when indicated.
Sections du résumé
BACKGROUND
BACKGROUND
To evaluate whether infectious illness symptoms (IIS) are associated with generalized anxiety symptoms during the COVID-19 pandemic in sexual/gender (SGM) minority young adults assigned male at birth (AMAB).
METHOD
METHODS
Four hundred eighteen participants (median age = 25; range, 20-40) were recruited through RADAR, an ongoing Chicago-based cohort study of SGM-AMAB between September 2020 and February 2021. Participants completed online surveys. A subset (n = 145) provided dried blood spot samples to assess SARS-CoV-2 serostatus.
RESULTS
RESULTS
One hundred twenty participants (28.7%) had GAD-7 scores of 10 or greater, which indicates generalized anxiety symptoms that may be clinically significant. In a binomial logistic regression model adjusting age, gender identity, race/ethnicity, substance use, and HIV status, the authors found that having a higher IIS count since March 1, 2020, was associated with greater odds of having a GAD-7 score of 10 or greater (OR = 1.14; 95% CI, 1.04, 1.25; P = 0.007). This effect was more pronounced in a binomial logistic regression model adjusting for the same covariates but using current IIS count as the independent variable (OR = 1.39; 95% CI, 1.13, 1.74; P = 0.002).
CONCLUSION
CONCLUSIONS
Among SGM-AMAB young adults, those who experienced ISS reported higher scores on the GAD-7, a widely used and validated screening measure for generalized anxiety symptoms. These findings highlight the importance of screening for anxiety disorders when patients present with IIS in clinical settings and psychobehavioral health follow-ups when indicated.
Identifiants
pubmed: 38241000
doi: 10.1007/s12529-023-10251-5
pii: 10.1007/s12529-023-10251-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDA NIH HHS
ID : U24 DA044554
Pays : United States
Organisme : NIDA NIH HHS
ID : 3U24DA044554- 04S1
Pays : United States
Organisme : NIDA NIH HHS
ID : 3U01DA036939-06S1
Pays : United States
Informations de copyright
© 2024. International Society of Behavioral Medicine.
Références
CDC. CDC COVID data tracker. Data Tracker Home 2022 [cited 2022 April 1]; Available from: https://covid.cdc.gov/covid-data-tracker/#datatracker-home .
WHO. WHO Coronavirus (COVID-19) Dashboard. 2023 June 21, 2023 June 21, 2023]; Available from: https://covid19.who.int/ .
Torales J, et al. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. 2020;66(4):317–20.
doi: 10.1177/0020764020915212
pubmed: 32233719
Rajkumar RP. COVID-19 and mental health: a review of the existing literature. Asian J Psychiatr. 2020;52:102066.
doi: 10.1016/j.ajp.2020.102066
pubmed: 32302935
pmcid: 7151415
Plöderl M, Tremblay P. Mental health of sexual minorities. A systematic review. Int Rev Psychiatry. 2015;27(5):367–385.
Dorn AV, Cooney RE, Sabin ML. COVID-19 exacerbating inequalities in the US. Lancet. 2020;395(10232):1243–4.
doi: 10.1016/S0140-6736(20)30893-X
pubmed: 32305087
pmcid: 7162639
Xiong J, et al. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 2020;277:55–64.
doi: 10.1016/j.jad.2020.08.001
pubmed: 32799105
pmcid: 7413844
Serafini G, et al. The psychological impact of COVID-19 on the mental health in the general population. QJM. 2020.
Cordaro M, et al. Pandemic-specific factors related to generalized anxiety disorder during the initial COVID-19 protocols in the United States. Issues Ment Health Nurs. 2021;42(8):747–57.
doi: 10.1080/01612840.2020.1867675
pubmed: 33480832
Grupe DW, Nitschke JB. Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nat Rev Neurosci. 2013;14(7):488–501.
doi: 10.1038/nrn3524
pubmed: 23783199
pmcid: 4276319
Bridgland VME, et al. Why the COVID-19 pandemic is a traumatic stressor. PLoS ONE. 2021;16(1):e0240146.
doi: 10.1371/journal.pone.0240146
pubmed: 33428630
pmcid: 7799777
Mongelli F, et al. Minority stress and mental health among LGBT populations: an update on the evidence. 2019.
Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull. 2003;129(5):674–97.
doi: 10.1037/0033-2909.129.5.674
pubmed: 12956539
pmcid: 2072932
Su D, et al. Mental health disparities within the LGBT population: a comparison between transgender and nontransgender individuals. Transgend Health. 2016;1(1):12–20.
doi: 10.1089/trgh.2015.0001
pubmed: 29159294
pmcid: 5685247
Wilson C, Cariola LA. LGBTQI+ youth and mental health: a systematic review of qualitative research. Adolesc Res Rev. 2020;5(2):187–211.
doi: 10.1007/s40894-019-00118-w
King M, et al. A systematic review of mental disorder, suicide, and deliberate self harm in lesbian, gay and bisexual people. BMC Psychiatry. 2008;8(1):1–17.
doi: 10.1186/1471-244X-8-70
Gato J, et al. Psychosocial effects of the COVID-19 pandemic and mental health among LGBTQ+ young adults: a cross-cultural comparison across six nations. J Homosex. 2021;68(4):612–30.
doi: 10.1080/00918369.2020.1868186
pubmed: 33480823
Kamal K, et al. Psychiatric impacts of the COVID-19 global pandemic on U.S. sexual and gender minority young adults. Psychiatry Res. 2021;299:113855.
Moore SE, et al. Disproportionate impact of the COVID-19 pandemic on perceived social support, mental health and somatic symptoms in sexual and gender minority populations. J Homosex. 2021;68(4):577–91.
doi: 10.1080/00918369.2020.1868184
pubmed: 33399504
Gallagher MW, et al. The impact of COVID-19 experiences and associated stress on anxiety, depression, and functional impairment in American adults. Cognit Ther Res. 2020;1–9.
Salerno JP, et al. Sexual and gender minority stress amid the COVID-19 pandemic: implications for LGBTQ young persons’ mental health and well-being. Public Health Rep. 2020;135(6):721–7.
doi: 10.1177/0033354920954511
pubmed: 33026972
pmcid: 7649999
Salim S, Chugh G, Asghar M. Chapter one - Inflammation in anxiety, in advances in protein chemistry and structural biology. Donev R., Editor. Academic Press. 2012;1–25.
Hou R, Baldwin DS. A neuroimmunological perspective on anxiety disorders. Hum Psychopharmacol Clin Exp. 2012;27(1):6–14.
doi: 10.1002/hup.1259
Lasselin J, et al. Mood disturbance during experimental endotoxemia: predictors of state anxiety as a psychological component of sickness behavior. Brain Behav Immun. 2016;57:30–7.
doi: 10.1016/j.bbi.2016.01.003
pubmed: 26790758
Schrock JM, et al. Traumatic events and mental health: the amplifying effects of pre-trauma systemic inflammation. Brain Behav Immun. 2021;98:173–84.
doi: 10.1016/j.bbi.2021.08.208
pubmed: 34391815
pmcid: 8588867
Schrock JM, Snodgrass JJ, Sugiyama LS. Lassitude: the emotion of being sick. Evol Hum Behav. 2020;41(1):44–57.
doi: 10.1016/j.evolhumbehav.2019.09.002
Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–15.
doi: 10.1038/s41591-021-01283-z
pubmed: 33753937
pmcid: 8893149
Mazza MG, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594–600.
doi: 10.1016/j.bbi.2020.07.037
pubmed: 32738287
pmcid: 7390748
Harris PA, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
doi: 10.1016/j.jbi.2019.103208
pubmed: 31078660
pmcid: 7254481
Baum MK, et al. HIV, psychological resilience, and substance misuse during the COVID-19 pandemic: a multi-cohort study. Drug Alcohol Depend. 2022;231:109230.
doi: 10.1016/j.drugalcdep.2021.109230
pubmed: 34998257
McDade TW, et al. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay. PLoS ONE. 2020;15(8):e0237833.
doi: 10.1371/journal.pone.0237833
pubmed: 32797108
pmcid: 7428174
McDade TW, et al. Symptoms of COVID-19 infection and magnitude of antibody response in a large community-based study. medRxiv. 2021;2021.02.04.21251170.
Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.
doi: 10.1001/archinte.166.10.1092
pubmed: 16717171
Bohn MJ, Babor TF, Kranzler HR. The alcohol use disorders identification test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995;56(4):423–32.
doi: 10.15288/jsa.1995.56.423
pubmed: 7674678
Hamilton CM, et al. The PhenX Toolkit: get the most from your measures. Am J Epidemiol. 2011;174(3):253–60.
doi: 10.1093/aje/kwr193
pubmed: 21749974
pmcid: 3141081
Gorbach PM, C3PNO. Collaborating consortium of cohorts producing NIDA opportunities (C3PNO) COVID-19 related survey for HIV/AIDS and substance using populations. 2020.
Groff D, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568–e2128568.
doi: 10.1001/jamanetworkopen.2021.28568
pubmed: 34643720
pmcid: 8515212
Löwe B, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 2008;46(3):266–74.
doi: 10.1097/MLR.0b013e318160d093
pubmed: 18388841
National Comorbidity Survey (NCS). NCS-R lifetime prevalence estimates. 2011. 2007 5 November 2023]; Available from: http://www.hcp.med.harvard.edu/ncs/ftpdir/NCS-R_Lifetime_Prevalence_Estimates.pdf .
Klaser K, et al. Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app. J Neurol Neurosurg Psychiatry. 2021;92(12):1254–8.
doi: 10.1136/jnnp-2021-327565
pubmed: 34583944
Fancourt D, Steptoe A, Bu F. Psychological consequences of long COVID: comparing trajectories of depressive and anxiety symptoms before and after contracting SARS-CoV-2 between matched long- and short-COVID groups. Br J Psychiatry. 2023;222(2):74–81.
doi: 10.1192/bjp.2022.155
pubmed: 36458509
pmcid: 7614126
Schrock JM, et al. Cohabitation with a known coronavirus disease 2019 case is associated with greater antibody concentration and symptom severity in a community-based sample of seropositive adults. Open Forum Infect Dis. 2021;8(7).
Mirzaei H, et al. COVID-19 among people living with HIV: a systematic review. AIDS Behav. 2021;25(1):85–92.
doi: 10.1007/s10461-020-02983-2
pubmed: 32734438
Bosh K, et al. Estimated annual number of HIV infections - United States, 1981–2019. MMWR Morb Mortal Wkly Rep. 2021;70(22);801–806.
Hoehn-Saric R, et al. Somatic symptoms and physiologic responses in generalized anxiety disorderand panic disorder: an ambulatory monitor study. Arch Gen Psychiatry. 2004;61(9):913–21.
doi: 10.1001/archpsyc.61.9.913
pubmed: 15351770